Altenstadt, France

Michel Lanoux

This inventor holds 1 USPTO granted patent. Top assignee: Odam, S.a.. Active years: 1995.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Michel Lanoux

Introduction

Michel Lanoux is a notable inventor based in Altenstadt, France. He has made significant contributions to the field of medical technology, particularly in the development of monitoring systems for patients. His work focuses on enhancing the safety and effectiveness of medical examinations.

Latest Patents

Lanoux holds a patent for a "Monitor for surveying the vital physiological parameters of a patient." This innovative device is designed to monitor the vital physiological signs of patients undergoing examination by nuclear magnetic resonance imaging. The monitor is constructed to ensure that each functional module is individually protected from the electromagnetic environment and high-frequency parasitic currents. Additionally, the control assembly is a computer system that does not utilize magnetic storage, enhancing its reliability and performance.

Career Highlights

Throughout his career, Michel Lanoux has been associated with Odam, S.A., where he has contributed to various projects aimed at improving patient monitoring technologies. His expertise in this area has positioned him as a valuable asset in the medical technology sector.

Collaborations

Lanoux has worked alongside notable colleagues, including Michel Kraemer and Gerard Muller. Their collaborative efforts have further advanced the development of innovative medical devices.

Conclusion

Michel Lanoux's contributions to medical technology, particularly through his patented monitoring system, highlight his commitment to improving patient care. His work continues to influence the field and showcases the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…